ORLYNVAH
Nov 08, 2024
ORLYNVAH – The First Oral Penem in the US Market: A New Era in UTI Treatment
Urinary tract infections (UTIs) are among the most prevalent bacterial infections in the US and globally. Around 60% of women will experience an uncomplicated UTI (uUTI) during their lifetime, and up to 40% of women with a history of uUTIs may face a recurrence, according to Iterum’s approval announcement. In 20...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
